Petros Pharmaceuticals Inc (PTPI)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current PTPI market cap is 2.17M. The company's latest EPS is USD -1.9734 and P/E is -0.16.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.52M | 1.99M | 1.68M | -365k | 1.39M |
| Operating Income | -1.31M | -2.46M | -4.81M | -5.04M | -3.93M |
| Net Income | -1.39M | -2.55M | -4.89M | -4.99M | -8.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 15.58M | 9.56M | 7.81M | 9.38M | 5.82M |
| Operating Income | -16.87M | -17.28M | -18.05M | -19.92M | -13.62M |
| Net Income | -32.51M | -20.59M | -8.99M | -20.04M | -13.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.57M | 28.73M | 38.91M | 33.8M | 30.31M |
| Total Liabilities | 15.12M | 15.78M | 31.86M | 21.32M | 19.62M |
| Total Equity | 15.45M | 12.94M | 6.93M | 12.07M | 9.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 58.37M | 69.85M | 67.39M | 32.42M | 33.8M |
| Total Liabilities | 50.35M | 52.39M | 31.85M | 15.72M | 21.32M |
| Total Equity | 8.02M | 17.47M | 35.55M | 16.7M | 12.07M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -748k | -1.32M | -5.37M | -7.63M | -1.14M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -358k | -721k | 13.91M | 11.54M | -1.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.53M | -15.31M | -11.86M | -12.8M | -7.63M |
| Investing | -72k | -5k | N/A | N/A | N/A |
| Financing | -3.11M | 30.3M | 18.57M | -1.62M | 11.54M |
| Market Cap | 2.17M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0.37 |
| Price to Cash Ratio | 0.16 |
| Price to Book Ratio | 0.17 |
| Dividend Yield | - |
| Shares Outstanding | 7M |
| Average Volume (1 week) | 110.17k |
| Average Volume (1 Month) | 316.17k |
| 52 Week Change | -90.09% |
| 52 Week High | 3.25 |
| 52 Week Low | 0.3006 |
| Spread (Intraday) | 0.01 (3.09%) |
| Company Name | Petros Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.petrospharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
